ReviewMolecular syndromology2025
One-Carbon Metabolism and Midbrain Dopaminergic Cells in Lesch-Nyhan Disease.
Review in Molecular syndromology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Lesch-Nyhan disease (LND) is characterized by severe motor problems, self-injury, and gout. LND is caused by loss of function of HPRT which functions to salvage purine nucleotides, but the link between purine recycling and the neurological phenotypes remains unknown. One-carbon metabolism (OCM) is the utilization of single-carbon units for important cellular pathways such as de novo purine synthesis, the methionine cycle, and the transsulfuration pathway. Since purine salvage is lost in LND and one-carbon groups are required for de novo purine synthesis, there is an obligate need to re-route one-carbon flux in LND. Midbrain dopaminergic neurons have been associated with LND and may represent an important intersection point for OCM and LND. Summary: In this review, we analyze the relationships between HPRT loss, OCM, and the unique metabolic features of midbrain dopaminergic cells. Our hope is to better understand how changes to metabolic flux in OCM might affect midbrain dopaminergic cells and ultimately lead to the neurological phenotypes of LND. Key Messages: OCM provides important components for different processes and pathways including de novo purine synthesis, methionine cycle, transsulfuration pathway, and polyamine synthesis. Changes in flux toward de novo purine synthesis in LND may affect these interconnected processes and have potential effects on dopaminergic cells as discussed in this review.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.